Skip to main content
Top
Published in: Intensive Care Medicine 10/2003

01-10-2003 | Editorial

Weapons of pressure resuscitation for septic shock

Author: Claudio Martin

Published in: Intensive Care Medicine | Issue 10/2003

Login to get access

Excerpt

While the subject of this analogy is intended to take lives, the weapons we use to resuscitate patients with septic shock are meant to save lives. Debate continues whether an ideal weapon exists, despite many investigations over a number of years. Clearly, patients with severe shock that is left untreated will die, while treatment with fluids and vasopressors can result in at least short-term survival (although patients may subsequently die of underlying disease). This constitutes level 1 evidence for the intervention, even in the absence of a randomized controlled trial [1]. However, we continue to seek proof that any one method of resuscitation is superior. Recent commentaries supporting norepinephrine [2] or dopamine [3] as the initial vasopressor for treatment of septic shock highlight the lack of consensus and supporting evidence. Both articles conclude by stating that well-designed, prospective randomized clinical trials are needed. …
Literature
1.
go back to reference Ball C, Sackett DL, Phillips B, Haynes B, Straus S (2003) Levels of evidence and grades of recommendations. NHS Res Dev. Available from: http://www.indigojazz.co.uk/cebm/levels_of_evidence.asp Ball C, Sackett DL, Phillips B, Haynes B, Straus S (2003) Levels of evidence and grades of recommendations. NHS Res Dev. Available from: http://​www.​indigojazz.​co.​uk/​cebm/​levels_​of_​evidence.​asp
2.
go back to reference Sharma VK, Dellinger RP (2003) The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine. Crit Care 7:3–5CrossRefPubMed Sharma VK, Dellinger RP (2003) The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine. Crit Care 7:3–5CrossRefPubMed
3.
go back to reference Vincent JL, De Backer D (2003) The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is dopamine rather than norepinephrine. Crit Care 7:6–8CrossRefPubMed Vincent JL, De Backer D (2003) The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is dopamine rather than norepinephrine. Crit Care 7:6–8CrossRefPubMed
4.
go back to reference Russell JA, Cooper DJ, Walley KR, Holmes CL, Singer J, Hebert PC, Granton J, Mehta S, Terins T (2003) Vasopressin and Septic Shock Trial (VASST): baseline characteristics and organ dysfunction in vasopressor dependent patients with septic shock. Am J Resp Crit Care Med 167:A548 Russell JA, Cooper DJ, Walley KR, Holmes CL, Singer J, Hebert PC, Granton J, Mehta S, Terins T (2003) Vasopressin and Septic Shock Trial (VASST): baseline characteristics and organ dysfunction in vasopressor dependent patients with septic shock. Am J Resp Crit Care Med 167:A548
5.
go back to reference Holmes CL, Patel BM, Russell JA, Walley KR (2001) Physiology of vasopressin relevant to management of septic shock. Chest 120:989–1002PubMed Holmes CL, Patel BM, Russell JA, Walley KR (2001) Physiology of vasopressin relevant to management of septic shock. Chest 120:989–1002PubMed
6.
go back to reference Scott JA, Mehta S, Duggan M, Bihari A, McCormack DG (2002) Functional inhibition of constitutive nitric oxide synthase in a rat model of sepsis. Am J Respir Crit Care Med 165:1426–1432CrossRefPubMed Scott JA, Mehta S, Duggan M, Bihari A, McCormack DG (2002) Functional inhibition of constitutive nitric oxide synthase in a rat model of sepsis. Am J Respir Crit Care Med 165:1426–1432CrossRefPubMed
7.
go back to reference Scott JA, McCormack DG (1999) Selective in vivo inhibition of inducible nitric oxide synthase in a rat model of sepsis. J Appl Physiol 86:1739–1744 Scott JA, McCormack DG (1999) Selective in vivo inhibition of inducible nitric oxide synthase in a rat model of sepsis. J Appl Physiol 86:1739–1744
8.
go back to reference Martin CM, Sibbald WJ (1994) Modulation of hemodynamics and organ blood flow by nitric oxide synthase inhibition is not altered in normotensive, septic rats. Am J Respir Crit Care Med 150:1539–1544PubMed Martin CM, Sibbald WJ (1994) Modulation of hemodynamics and organ blood flow by nitric oxide synthase inhibition is not altered in normotensive, septic rats. Am J Respir Crit Care Med 150:1539–1544PubMed
9.
go back to reference Grover R, Zaccardelli D, Colice G, Guntupalli K, Watson D, Vincent JL (1999) An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med 27:913–922PubMed Grover R, Zaccardelli D, Colice G, Guntupalli K, Watson D, Vincent JL (1999) An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group. Crit Care Med 27:913–922PubMed
10.
go back to reference Grover R, Lopez A, Lorente J, Steingrub J, Bakker J, Willatts S, et al (1999) Multi-center, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546C88. Crit Care Med 27:33A Grover R, Lopez A, Lorente J, Steingrub J, Bakker J, Willatts S, et al (1999) Multi-center, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546C88. Crit Care Med 27:33A
11.
go back to reference Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871PubMed Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871PubMed
12.
go back to reference Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26:645–650PubMed Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26:645–650PubMed
13.
go back to reference Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, et al (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27:723–732PubMed Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, et al (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27:723–732PubMed
14.
go back to reference Di Giantomasso D, May CN, Bellomo R (2003) Norepinephrine and vital organ blood flow. Intensive Care Med 28:1804–1809 Di Giantomasso D, May CN, Bellomo R (2003) Norepinephrine and vital organ blood flow. Intensive Care Med 28:1804–1809
15.
go back to reference Di Giantomasso D, May CN, Bellomo R (2003) Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis. Intensive Care Med (in press) Di Giantomasso D, May CN, Bellomo R (2003) Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis. Intensive Care Med (in press)
16.
go back to reference Bloos F, Martin CM, Ellis C, Sibbald WJ (1999) Effects of modest anemia on systemic and coronary circulation of septic sheep. Am J Physiol Heart Circ. Physiol:H2195-H2204 Bloos F, Martin CM, Ellis C, Sibbald WJ (1999) Effects of modest anemia on systemic and coronary circulation of septic sheep. Am J Physiol Heart Circ. Physiol:H2195-H2204
17.
go back to reference Martin CM, Yaghi A, Sibbald WJ, McCormack D, Paterson NAM (1993) Differential impairment of vascular reactivity of small pulmonary and systemic arteries in hyperdynamic sepsis. Am Rev Respir Dis 148:164–172PubMed Martin CM, Yaghi A, Sibbald WJ, McCormack D, Paterson NAM (1993) Differential impairment of vascular reactivity of small pulmonary and systemic arteries in hyperdynamic sepsis. Am Rev Respir Dis 148:164–172PubMed
18.
go back to reference Martin C, Viviand X, Leone M, Thirion X (2000) Effect of norepinephrine on the outcome of septic shock. Crit Care Med 28:2758–2765 Martin C, Viviand X, Leone M, Thirion X (2000) Effect of norepinephrine on the outcome of septic shock. Crit Care Med 28:2758–2765
19.
go back to reference Sielenkamper A, Yu P, Eichelbronner O, MacDonald TL, Martin CM, Chin-Yee IH, Sibbald WJ (2000) Diaspirin cross-linked Hb and norepinephrine prevent the sepsis-induced increase in critical O2 delivery. Am J Physiol (Heart Circ Physiol) 279:H1922-H1930 Sielenkamper A, Yu P, Eichelbronner O, MacDonald TL, Martin CM, Chin-Yee IH, Sibbald WJ (2000) Diaspirin cross-linked Hb and norepinephrine prevent the sepsis-induced increase in critical O2 delivery. Am J Physiol (Heart Circ Physiol) 279:H1922-H1930
20.
go back to reference Marik PE, Mohedin M (1994) The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 272:1354–1357PubMed Marik PE, Mohedin M (1994) The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 272:1354–1357PubMed
21.
go back to reference Martin C, Papazian L, Perrin G, Saux P, Gouin F (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 101:1826–1831 Martin C, Papazian L, Perrin G, Saux P, Gouin F (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 101:1826–1831
Metadata
Title
Weapons of pressure resuscitation for septic shock
Author
Claudio Martin
Publication date
01-10-2003
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 10/2003
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-003-1794-z

Other articles of this Issue 10/2003

Intensive Care Medicine 10/2003 Go to the issue